GN

Genscript Biotech CorpOOTC GNNSF Stock Report

Last reporting period 31 Dec, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

3.003

Middle

Exchange

OOTC - OTC

View Section: Company Analysis

Genscript Rating

GN

GNNSF stock rating score is -12/100. Genscript is aExtremely Risky Investment.

The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.

Eyestock Rating

Last update 16.05.2024

-12/100

Low score

Rating Breakdown

  • Profitability score

    -2

    /25

  • Solvency score

    8

    /25

  • Efficiency score

    -17

    /25

  • Stability score

    -2

    /25

Genscript Biotech Corp Rewards and Warnings

The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.

Financial

Check

Value

Net Profit Margin

-11 %

Earnings quality

Gross Margin

49 %

Genscript Biotech Corp's Historical Rating

How has the company's valuation changed in the past?

A quick analysis will help you understand how stable financial indicators are overall.


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Discover High-rated Companies


View Section: Valuation